NASDAQ$ASRT

Assertio Holdings Inc · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

Reported a net income of $8.5 million and net product sales increased by 13% year-over-year.

Assertio Holdings reported a strong second quarter with a 13% increase in net product sales, reaching $40.1 million. The acquisition of Spectrum Pharmaceuticals is expected to enhance the company's revenue base and commercial capabilities. The company generated $18.6 million in cash flow from operations.

  • Net product sales increased by 13% year-over-year, reaching $40.1 million.
  • Gross margin increased to 88.1% from 87.2% in the prior year quarter.
  • Adjusted EBITDA increased to $24.8 million from $22.9 million in the prior year quarter.
  • Cash and cash equivalents totaled $70.2 million at quarter end.

Headline financials

Total Revenue

$41M

Previous: $35.1M+16.7%
EPS (adj)

$0.19

Previous: $0.28-32.1%
Adjusted EBITDA

$24.8M

Previous: $22.9M+8.3%
Gross Margin

88.1%

Previous: 87.2%+1.0%
Capital Expenditures

-$528K

No prior period
Free Cash Flow

$7.94M

Previous: $7.83M+1.4%
Net Income

$8.47M

Previous: $7.83M+8.1%
Operating Income

$12.4M

Previous: $10.8M+15.1%
Gross Profit

-$4.77M

Previous: -$4.53M-5.4%
Cash & Equivalents

$70.2M

Previous: $52.3M+34.3%
Total Assets

$405M

Previous: $322M+25.8%
Stock-Based Comp

$2.21M

Previous: $1.73M+27.2%

Revenue & EPS history

Assertio · Revenue · Quarterly

$41M

Q2 2023+16.7%vs Q2 2022
Beat estimate in 11 of 14 quarters(79%)
ActualEstimate

Revenue by segment

Assertio · $40.1M total across 1 segment · Q2 2023

  • Net Product Sales
    $40.1M

Forward guidance

Assertio is withdrawing its 2023 financial outlook to assess the recent news of a generic indomethacin suppository approved by the United States Food and Drug Administration (“FDA”).

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-1.9%

Avg return

Earnings day

-4.4%

Avg return

5 days after

-4.5%

Avg return

30 days after

52%

33 / 64 earnings

Positive

+33.3%

Q3 2021

Best reaction

-46.2%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.5%+4.2%+4.7%
Q4 2025+6.5%+13.6%+53.1%
Q3 2025+13.3%-1.2%-1.2%
Q1 2025-1.8%+8.1%+0.0%
Q4 2024-7.5%-7.7%-20.5%
Q3 2024+0.2%-4.7%+12.9%
Q2 2024-12.8%-14.4%+0.8%
Q1 2024+7.8%-6.8%-2.9%
Q4 2023+10.8%+23.1%-1.1%
Q3 2023-45.5%-53.2%-50.9%
Q2 2023-46.2%-41.0%-39.0%
Q1 2023+20.6%+22.2%-3.8%
Q4 2022+7.9%-15.1%-0.6%
Q3 2022-0.4%+10.4%+38.1%
Q2 2022-4.3%-4.8%-32.6%
Q1 2022+6.2%+37.5%+52.9%
Q4 2021+13.8%-0.5%+56.9%
Q3 2021+33.3%+36.0%+18.4%
Q2 2021-2.3%-3.1%-16.3%
Q1 2021+11.8%-3.9%-11.8%
Q4 2020+4.3%-3.2%-35.1%
Q3 2020-41.8%-40.3%-37.3%
Q2 2020-13.8%-18.1%-23.4%
Q1 2020+1.3%+1.2%+21.3%
Q4 2019-35.1%-29.8%-37.7%
Q3 2019-9.6%-13.3%-14.5%
Q2 2019+1.4%-45.1%-54.2%
Q1 2019-0.4%-10.8%-37.9%
Q4 2018-5.8%-12.7%+26.8%
Q3 2018+6.5%+5.5%-16.3%
Q2 2018-19.0%-23.0%-33.5%
Q1 2018+26.5%+23.5%+10.6%
Q4 2017-11.4%-12.3%-15.0%
Q3 2017+15.4%+30.0%+68.6%
Q2 2017-35.1%-33.3%-37.4%
Q1 2017+2.3%+9.0%-3.1%
Q4 2016+4.7%-0.9%-9.9%
Q3 2016-16.1%-8.0%-12.1%
Q2 2016+5.6%+10.2%+8.7%
Q1 2016-6.2%
Q4 2015-4.1%
Q3 2015+6.7%
Q2 2015-7.2%
Q1 2015-14.1%
Q4 2014+13.4%
Q3 2014-2.7%
Q2 2014+5.5%
Q1 2014-23.5%
Q4 2013+14.8%
Q3 2013-0.5%
Q2 2013+4.0%
Q1 2013-2.8%
Q4 2012+6.2%
Q3 2012+1.5%
Q2 2012-0.5%
Q1 2012+3.2%
Q4 2011+3.3%
Q3 2011-10.4%
Q2 2011+3.1%
Q1 2011-1.2%
Q4 2010+0.6%
Q3 2010-0.2%
Q2 2010+5.2%
Q1 2010-4.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro